Indole derivatives as 5-HT1A antagonists and as inhibitors of serotonine reuptake
申请人:ELI LILLY AND COMPANY
公开号:EP0814084A1
公开(公告)日:1997-12-29
A series of 1-(4-indolyloxy)-3-(4-hydroxy-4-naphthylpiperidin-1-yl)propanes are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1A receptor, yet lack mutagenic potential as measured by assays of chromosomal aberration. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.
Indole derivative as 5-HT1A antagonist and as inhibitor of serotonine reuptake
申请人:ELI LILLY AND COMPANY
公开号:EP0814084B1
公开(公告)日:2001-08-08
Compounds having effects on serotonin-related systems
申请人:Eli Lilly and Company
公开号:US05912256A1
公开(公告)日:1999-06-15
A series of 1-(4-indolyloxy)-3-(4-hydroxy-4-naphthylpiperidin-1-yl)propanes are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1.sub.A receptor, yet lack mutagenic potential as measured by assays of chromosomal aberration. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.